novartis to release new gene therapy drug that could cost $2 million
Published 5 years ago • 1.6K plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
5:41
who pays for a $2 million life-saving drug?
-
1:01
fda approves novartis gene therapy for rare genetic disorder
-
4:22
novartis ceo on new cancer therapy programs
-
3:29
novartis generated $40 billion in innovative medicine sales, says ceo
-
0:37
novartis & voyager therapeutics inked a deal to develop gene therapies for huntington’s and sma
-
3:37
novartis' $8.7 billion deal for gene therapy company avexis
-
5:48
novartis acquires the medicines company for $9.7 billion
-
1:00:12
the future of medicine: crispr, drug prices & gene therapy
-
6:10
the science behind aduhelm, a controversial new alzheimer’s drug | wsj
-
5:48
gene therapy offers hope for untreatable cancers | dw news
-
0:57
what you need to know about biogen’s new alzheimer’s treatment
-
4:42
novartis can meet growing demand for gene therapy: ceo
-
2:02
$2m gene therapy drug
-
2:48
new drug that could save infants' lives has $2m price tag
-
3:28
seeking to enable a future of cell and gene therapies
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
3:57
experimental alzheimer's drug gives renewed hope
-
2:53
novartis ceo on the development of ai tech in health care
-
3:09
meet leila: explorer of a future with gene therapy
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
0:28
novartis acquiring cancer drug developer morphosys for €2.7 billion
-
2:05
$2m gene therapy for rare disorder is world's most expensive drug